Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bupivacaine + fentanyl is a combination medication used for pain management, particularly in epidural and intrathecal (spinal) analgesia. This combination leverages the synergistic interaction between these two medications to provide effective pain relief with potentially fewer side effects than higher doses of either medication alone. Bupivacaine is an amide local anesthetic that blocks nerve impulse generation and conduction, while fentanyl is an opioid analgesic that acts on the central nervous system. The combination is commonly used for labor pain relief, post-surgical pain management, and in the management of chronic pain through intrathecal drug delivery systems.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bupivacaine + fentanyl.